The “Diagnostic Radiopharmaceuticals & Contrast Media Market” research report 2019 delivers comprehensive information about the market ranging from the establishment to the predictable growth trend. Diagnostic Radiopharmaceuticals & Contrast Media market report provides brief analytical data of the market contenders globally using advanced methodological approaches, such as SWOT analysis, production chain, cost, sales margin, financial details, recent developments. Diagnostic Radiopharmaceuticals & Contrast Media market report also offers market competitors that includes detailed company profiles along with company product specifications.
Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999529
In Diagnostic Radiopharmaceuticals & Contrast Media Market Report, Following Companies Are Covered:
Diagnostic Radiopharmaceuticals & Contrast Media Market 2019 report will help the industry aspirants in arranging their strategies. The measurements offered in this report will be an exact and helpful manual to shape the business development. Additionally, will Provide historical data along with a future forecast and detailed analysis and also expected opportunities.
Scope of the Report:
Reasons for Buying Diagnostic Radiopharmaceuticals & Contrast Media Market Report:
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a five-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999529
Key Market Trends:
Cardiology Sub-segment Captured the Largest Market Share and is Expected to Retain its Dominance
The major factor driving the growth of the market is the rising prevalence of cardiovascular diseases over the world. According to the estimates of the World Health Organization (WHO), in 2016, 17.9 million people died from CVDs. SPECT, which stands for single photon emission computed tomography, is a non-invasive procedure that can accurately identify areas of abnormal myocardial perfusion. It is also used to determine the functional capacity of the heart muscle and is able to separate living tissue from an irreversibly damaged tissue. This diagnostic procedure helps physicians find out if there are blockages in the coronary (heart) arteries, as well as to determine if the patient should undergo a coronary angiogram. In SPECT, cardiac-specific radiopharmaceuticals, such as 99mTc-tetrofosmin (Myoview, GE healthcare), 99mTc-sestamibi (Cardiolite, Bristol-Myers Squibb), or Thallium-201 chloride are administered. Hence, factors, such as the rising prevalence of cardiovascular diseases and technological advancements in the field of diagnostics, are expected to drive the growth of the market over the forecast period.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America dominated the overall diagnostic radiopharmaceuticals and contrast media market, with the United States accounting for the major contributor to the market. The US diagnostic radiopharmaceuticals and contrast media market is anticipated to continue its expansion over the forecast period. The first gadolinium-based contrast agent was approved in the United States. Four agents were approved in the United States in the past decade, and they have set a string trend in the industry to continue to find more efficient, accurate, and safe agents.
The contrast media sales are expected to increase in the United States in the coming years. Among the different imaging modalities, sales of contrast media for the ultrasound market are likely to have a considerable growth rate. Diagnostic radioisotopes are a significant component of the US economy. Increase in chronic cardiac and neurological diseases is the primary driving factor for the market growth in the United States. Hence, the North American diagnostic radiopharmaceuticals and contrast media market is expected to retain its dominance over the forecast period.
The Research Document Will Answer Following Questions Such as:
- What are the cutting-edge technologies responsible for driving the growth of the market?
- What are the main applications of the market? What are the growth prospects to the market applications into the market?
- At what stage of development are the key market products?
- What are the shortcomings that has to face to become commercially viable? Is their growth and commercialization dependent on cost declines or technological/application breakthroughs?
- What is the outlook for the industry?
- What difference does performance characteristics of Diagnostic Radiopharmaceuticals & Contrast Media create from those of established entities?
Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/13999529
Detailed TOC of Diagnostic Radiopharmaceuticals & Contrast Media Market Report 2019-2024:
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technology Advancements in Medical Imaging
4.2.2 Increasing Demand for Image-guided Procedures and Diagnostics
4.2.3 High Prevalence of Cancers and Cardiac Diseases
4.3 Market Restraints
4.3.1 High Costs of the Techniques- Not Easily Affordable
4.3.2 Limited Health Insurance Coverage
4.3.3 Short Half-life of Radiopharmaceuticals
4.4 Industry Attractiveness Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1.1 By Type of Imaging Modality
220.127.116.11.5 Other SPECTs
18.104.22.168.3 Other PETs
5.1.2 By Application
22.214.171.124 Diagnostic Application
126.96.36.199.1 SPECT Applications
188.8.131.52.1.4 Other SPECT Applications
184.108.40.206.2 PET Application
220.127.116.11.2.4 Other PET Applications
18.104.22.168 Therapeutic Application
22.214.171.124.3 Endocrine Tumors
126.96.36.199.4 Other Therapeutic Applications
5.2 Contrast Media
5.2.1 By Application
188.8.131.52 Ionizing Radiation-based Radioimaging
184.108.40.206 Non-Ionizing Radiation-based Radioimaging
5.2.2 By Procedure
220.127.116.11 X-ray/Computed Tomography (CT)
18.104.22.168.1 Iodinated Contrast Media Ionic
22.214.171.124.2 Iodinated Contrast Media Non-Ionic
126.96.36.199.3 Barium-based Contrast Media
188.8.131.52 Magnetic Resonance Imaging (MRI)
184.108.40.206.1 Gadolinium-based Contrast Media
220.127.116.11.2 Other Magnetic Resonance Imaging
5.2.3 By Indication
18.104.22.168 Cardiovascular Disease
22.214.171.124 Other Indications
5.3.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest of Europe
220.127.116.11 South Korea
18.104.22.168 Rest of Asia-Pacific
5.3.4 Middle East & Africa
22.214.171.124 South Africa
126.96.36.199 Rest of Middle East & Africa
5.3.5 South America
188.8.131.52 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.2 Bio-Optronics Inc.
6.1.3 DATATRAK International Inc.
6.1.4 ERT Clinical
6.1.5 IBM Watson Health
6.1.6 Medidata Solutions Inc.
6.1.7 MedNet Solutions Inc.
6.1.8 Oracle Corporation
6.1.9 Parexel International Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Name: Ajay More
Phone: US +14242530807/ UK +44 20 3239 8187
Email: [email protected]
Our Other Reports: